SlideShare is now on Android. 15 million presentations at your fingertips.  Get the app

×
  • Share
  • Email
  • Embed
  • Like
  • Save
  • Private Content
 

Bioheart (OTC: BHRT; Twitter: $BHRT)

by on Apr 12, 2011

  • 1,934 views

Bioheart (OTC: BHRT; Twitter: $BHRT) seeks to be the "go to technology partner for heart failure specialists and their patients".

Bioheart (OTC: BHRT; Twitter: $BHRT) seeks to be the "go to technology partner for heart failure specialists and their patients".

Statistics

Views

Total Views
1,934
Views on SlideShare
1,658
Embed Views
276

Actions

Likes
3
Downloads
100
Comments
1

7 Embeds 276

http://www.proactivenewsroom.com 265
url_unknown 4
http://slblst01.uafortsmith.edu 2
http://wordpress 2
http://cursos.itesm.mx 1
http://translate.googleusercontent.com 1
http://eleap.ust.edu.ph 1
More...

Accessibility

Upload Details

Uploaded via SlideShare as Microsoft PowerPoint

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel

11 of 1 previous next

  • MarkSussman Mark Sussman at SDSU (San Diego State University) This is far from an unbiased presentation, but a corporate pitch for investment. It's important to recognize and discriminate an impartial review from a sales job. There are excellent results from clinical trials using mesenchymal stem cells for allogenic therapy as well as cardiac stem cells for autologous therapy currently in clinical trials for heart failure. Also, the issues of myoblast engraftment, electrical coupling, durability of repair, and contribution to contractile performance of the heart remain. It is certainly possible that recruitment and activation of endogenous repair mechanisms plays a significant role in the observed effects that are, in fact, achievable with a variety of cell types other than myoblasts. The concept of myoblast therapy has had a decade-long head start in research because it began long before stem endogenous stem cell pools were recognized as participants in active ongoing tissue repair throughout life. Other tissue-specific stem cell types are catching up fast. 2 years ago
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

Bioheart (OTC: BHRT; Twitter: $BHRT) Bioheart (OTC: BHRT; Twitter: $BHRT) Presentation Transcript